Strides Pharma Science Ltd (BOM:532531)
ā‚¹ 1634.5 39.35 (2.47%) Market Cap: 150.72 Bil Enterprise Value: 170.45 Bil PE Ratio: 64.92 PB Ratio: 6.62 GF Score: 68/100

Q4 2020 Strides Pharma Science Ltd Earnings Call Transcript

May 21, 2020 / 03:00AM GMT
Release Date Price: ā‚¹421.3 (+0.06%)
Operator

Ladies and gentlemen, good day, and welcome to the Strides Pharma Science Limited Q4 FY '20 Earnings Conference Call. (Operator Instructions) Please note, this conference is being recorded.

I now hand the conference over to Mr. Abhishek Singhal. Thank you, and over to you, sir.

Abhishek Singhal

Good morning, and thank you for joining us today for Strides earnings call for the fourth quarter and full year ended financial year 2020. Today, we have with us Arun, Founder and Chairman; Dr. Ananth, Chief Executive Officer and Managing Director; and Badree, Executive Director of Finance, to share the highlights of the business and financials for the quarter.

I hope you've gone through our results release and the quarterly investor presentation, which have been uploaded on our website as well as the stock exchange. The transcript of this call will be available in a week's time on the company's website. Please note that today's discussion may be forward-looking in nature and must be viewed in relation to the risks pertaining to our business. After the end of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot